Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPP3CC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | RP11-296A16.1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | PTPN18 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
mRNA | SYBU | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | ENKUR | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
mRNA | KLHL25 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
mRNA | BOLA2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | LRRC29 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | OPTN | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | GP1BB | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |